HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Renata Rao Selected Research

Monoclonal Antibodies

11/2023Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine.
11/2023Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study.
1/2023Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab.
11/2022Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients.
1/2022CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients.
1/2022Photophobia and migraine outcome during treatment with galcanezumab.
12/2021Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Renata Rao Research Topics

Disease

22Migraine Disorders (Migraine)
02/2024 - 09/2005
12Headache (Headaches)
01/2024 - 06/2013
4Pain (Aches)
02/2023 - 01/2022
2Prescription Drug Overuse
12/2020 - 01/2019
2Migraine with Aura (Familial Hemiplegic Migraine)
11/2006 - 09/2005
1Photophobia (Light Sensitivity)
01/2022
1Disease Progression
01/2021
1Neurologic Manifestations (Neurological Manifestations)
12/2020
1COVID-19
01/2020
1Thyroiditis
04/2014
1Status Epilepticus (Complex Partial Status Epilepticus)
04/2014
1Hashimoto's encephalitis
04/2014
1Brain Diseases (Brain Disorder)
04/2014

Drug/Important Bio-Agent (IBA)

7galcanezumabIBA
02/2024 - 05/2021
7Monoclonal AntibodiesIBA
11/2023 - 12/2021
5Analgesics (Analgesic Drugs)IBA
11/2023 - 12/2021
5erenumabIBA
11/2023 - 12/2020
3Type A Botulinum Toxins (Botox)FDA Link
11/2023 - 01/2018
3fremanezumabIBA
11/2023 - 11/2022
3Calcitonin Gene-Related PeptideIBA
11/2023 - 12/2021
2VaccinesIBA
01/2024 - 01/2022
2Tryptamines (Triptans)IBA
01/2022 - 01/2019
1COVID-19 VaccinesIBA
01/2022
1CytokinesIBA
01/2022
1Dihydrotachysterol (AT 10)IBA
12/2021
1IronIBA
01/2021
1Sodium Glutamate (Accent)IBA
12/2020
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
04/2014
1AntibodiesIBA
04/2014
1Retinaldehyde (Retinal)IBA
06/2013
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
11/2006
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2006
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
09/2005
1Serotonin (5 Hydroxytryptamine)IBA
09/2005

Therapy/Procedure

3Therapeutics
05/2021 - 04/2014
1Aftercare (After-Treatment)
12/2021
1Retreatment
12/2021
1Plasmapheresis
04/2014
1Plasma Exchange
04/2014